Zhejiang Taimei Medical Technology Co., Ltd.
Zhejiang Taimei Medical Technology Co., Ltd. provides digital operation platform for the biopharma industry in China. The company offers TrialOS, a drug digital cooperation platform that connects the cycle of hospitals, pharmaceutical companies, third-party providers, regulatory authorities, patients, and other industry stakeholders; PharmaOS, a pharmaceutical digital marketing platform; and Ente… Read more
Market Cap & Net Worth: Zhejiang Taimei Medical Technology Co., Ltd. (A2V)
Zhejiang Taimei Medical Technology Co., Ltd. (F:A2V) has a market capitalization of $104.92 Million (€102.22 Million) as of March 18, 2026. Listed on the F stock exchange, this Germany-based company holds position #21460 globally and #2330 in its home market, demonstrating a 4.51% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Zhejiang Taimei Medical Technology Co., Ltd.'s stock price €0.51 by its total outstanding shares 200425133 (200.43 Million).
Zhejiang Taimei Medical Technology Co., Ltd. Market Cap History: 2026 to 2026
Zhejiang Taimei Medical Technology Co., Ltd.'s market capitalization history from 2026 to 2026. Data shows growth from $104.92 Million to $104.92 Million (0.00% CAGR).
Zhejiang Taimei Medical Technology Co., Ltd. Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Zhejiang Taimei Medical Technology Co., Ltd.'s valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
No P/S ratio data available
Latest Price to Earnings (P/E) Ratio
No P/E ratio data available
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| No financial ratio data available | |||||
Competitor Companies of A2V by Market Capitalization
Companies near Zhejiang Taimei Medical Technology Co., Ltd. in the global market cap rankings as of March 18, 2026.
Key companies related to Zhejiang Taimei Medical Technology Co., Ltd. by market ranking:
- Veeva Systems Inc Class A (NYSE:VEEV): Ranked #724 globally with a market cap of $28.17 Billion USD.
- BrightSpring Health Services, Inc. Tangible Equity Unit (NASDAQ:BTSGU): Ranked #989 globally with a market cap of $19.86 Billion USD.
- BrightSpring Health Services, Inc. Common Stock (NASDAQ:BTSG): Ranked #2240 globally with a market cap of $6.77 Billion USD.
- HealthEquity Inc (NASDAQ:HQY): Ranked #2273 globally with a market cap of $6.65 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #724 | Veeva Systems Inc Class A | NYSE:VEEV | $28.17 Billion | $186.70 |
| #989 | BrightSpring Health Services, Inc. Tangible Equity Unit | NASDAQ:BTSGU | $19.86 Billion | $139.72 |
| #2240 | BrightSpring Health Services, Inc. Common Stock | NASDAQ:BTSG | $6.77 Billion | $42.10 |
| #2273 | HealthEquity Inc | NASDAQ:HQY | $6.65 Billion | $79.40 |
Zhejiang Taimei Medical Technology Co., Ltd. Historical Marketcap From 2026 to 2026
Between 2026 and today, Zhejiang Taimei Medical Technology Co., Ltd.'s market cap moved from $104.92 Million to $ 104.92 Million, with a yearly change of 0.00%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | €104.92 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of Zhejiang Taimei Medical Technology Co., Ltd. was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $104.92 Million USD |
| MoneyControl | $104.92 Million USD |
| MarketWatch | $104.92 Million USD |
| marketcap.company | $104.92 Million USD |
| Reuters | $104.92 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.